Market Challenges And Opportunities

Global Anhydrous Dibasic Calcium Phosphate Market– Drivers

Increasing launches of new supplements

Increasing launches of new supplements is expected to drive the global anhydrous dibasic calcium phosphate market growth over the forecast period. For instance, on January 06, 2022, Nutrazee, India based premium vegan supplement brand, announced the launch of Calcium + Vitamin D gummies for kids & adults. Nutrazee’s Calcium + D3 gummies are intended to supplement diet with calcium and vitamin D, which help support the bone health, teeth, and immune health. The gummies are 100% vegan and come in natural orange flavor. These are made of pectin (sourced from fruit), a plant-based alternate to animal-derived gelatin. The calcium is mainly prepared from anhydrous dibasic calcium phosphate which is expected to drive growth of global anhydrous dibasic calcium phosphate market.

Increasing research & development activities in anhydrous dibasic calcium phosphate

Increasing research & development activities in anhydrous dibasic calcium phosphate is expected to drive the global anhydrous dibasic calcium phosphate market growth. For instance, according to an article published by the Journal of Orthopedic Translation on February 03, 2022, a porous scaffold composed of pure magnesium particles and coated with dibasic calcium phosphate dehydrate (DCPD) coating were prepared using 3D gel printing technology. It was found that due to coating with DCPD, porosity and pore size can be controlled independently and accurately. The DCPD coated pure granular scaffold has suitable initial mechanical properties, good biocompatibility, and suitable degradation rate, which stimulates bone regeneration and mediates new bone formation and remodeling.

Growth Drivers:

Increasing launches of new supplements
Increasing research and development activities in anhydrous dibasic calcium phosphate

Global Anhydrous Dibasic Calcium Phosphate Market: Key Developments

On May 3, 2023, OceanTech Acquisitions, a U.S.-based a special purpose acquisition company, announced that it has entered into definitive agreement to combine Regentis Biomaterials Ltd., an Israel-based regenerative medicine company at US$ 95 million valuation. Or-Akiva, Israel-based Regentis has been working to commercialize its GelrinC orthopedic therapy to repair cartilage damage in knees and has already received a CE mark in Europe as a medical device. This orthopedic therapy requires anhydrous dibasic calcium phosphate as calcium supplement. The combined company is expected to trade on the Nasdaq once the deal is completed in the fourth quarter of 2023. Regentis shareholders are to receive US$ 95 million in OceanTech I shares at US$ 10 per share.

Global Anhydrous Dibasic Calcium Phosphate Market: Restraints

High cost of anhydrous dibasic calcium phosphate

The high cost of anhydrous dibasic calcium phosphate is expected to hamper the global anhydrous dibasic calcium phosphate market growth. For instance, according to an article published by the World Bank on May 11, 2022, fertilizer prices have risen nearly 30% since the start of 2022, following last year’s 80% surge. Soaring prices are driven by a confluence of factors, including surging input costs, supply disruptions, and export restrictions. The cost of phosphoric acid and calcium oxide, the starting ingredient in formation of anhydrous dibasic calcium phosphate has increased which increases concerns around fertilizer affordability and availability.

To counterbalance this restraint, more efficient sources and its supply methods should be identified.

Recalls of calcium supplements

Recalls of calcium supplements is expected to hamper the global anhydrous dibasic calcium phosphate market growth. For instance, on March 3, 2020, Purina Animal Nutrition LLC, a U.S. based animal nutrition company, announced voluntary recall of multiple lots of Purina Rabbit Feed, Purina Turkey Feed, Country Acres Rabbit Feed and DuMOR Chick Starter/Grower Feed due to elevated calcium levels in the product. Purina Animal Nutrition received reports from customers claiming the rabbit products may have resulted in poor health and/or mortality. Elevated calcium carbonate levels can cause health issues and potential mortality in rabbits. Continued feeding of these products may result in death as a result of feed refusal. Elevated calcium carbonate levels in young chickens and turkeys can lead to leg abnormalities and kidney calcification.

To counterbalance this restrain, more testing of products should be done to avoid such recalls.